Ambulero, Inc.
PrivateLast Round
VC Round
Jan 25, 2021
Company Overview
Ambulero, Inc. is a biotechnology company that develops cell and gene therapies for the treatment of vascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ambulero, Inc. Comparables
Compare Ambulero, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ixaka Ltd | 84% | |
| BioGenCell | 84% | |
| Libella Gene Therapeutics | 80% | |
Ambulero, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 25, 2021 |
Ambulero, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Orphinic Scientific SA | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 3, 2026
Monthly visitors increased 187% MoM.
- Jan 25, 2021
$5.5M round led by Orphinic Scientific SA
Ambulero, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ambulero, Inc.'s valuation, stock price, and market status.